Livi: The Groundbreaking Device Revolutionizing Post-Sex Intimate Health for Women

Introducing Livi: A New Era in Women's Health

In a significant advancement for women's intimate health, LiviWell Inc. has unveiled Livi®, the first device of its kind to receive FDA clearance for post-sex care. Available exclusively at MyLivi.com for just $13.99, Livi is designed to absorb semen and vaginal discharge after intercourse, meeting a long-ignored need in women's health.

Addressing Common Concerns

For many women, post-sex experiences can be accompanied by discomfort, odor, and discharge—issues that often go unaddressed in conventional conversations surrounding intimate health. The introduction of Livi aims to provide a discreet and effective solution to manage these concerns, enhancing overall well-being.

Dawn Halkuff, CEO of LiviWell, stated, "For far too long, women have been expected to simply accept common post-sex symptoms like odor and discharge. Bringing these everyday realities into the conversation is an important part of advancing women's intimate health."

Co-Founders Leading the Charge

LiviWell was co-founded by Dan Seewald, a former executive at Pfizer, and Dr. Michael Ingber, a board-certified urogynecologist. Their combined expertise brings a wealth of knowledge to the development of Livi, reflecting their understanding of the needs faced by women after intercourse.

As Seewald mentioned, the journey towards creating Livi involved listening to women's experiences and frustrations that had long been overlooked. "Meaningful innovation starts with listening. Conversations with women revealed a clear need for a medical solution designed specifically for post-sex care," he added.

How It Works

Livi is straightforward to use. The device is inserted vaginally via a familiar tampon-style applicator and absorbs fluids before being removed and discarded. It is intended for single use and is designed for ease and discretion, allowing women to incorporate it seamlessly into their post-intimacy routines.

Dr. Michael Ingber also highlighted the clinical aspect behind Livi’s development: "Women have shared frustrations around post-sex leakage and discomfort, yet there has never been a product specifically designed to address it. Livi offers a simple, discreet option that fits naturally into a woman's post-intimacy routine."

Supporting Innovation through Partnerships

The development of Livi was further supported by anchor investor Atlantic Health, providing essential financial and research resources to help navigate the regulatory landscape. This partnership underscores the commitment to improving women’s health and developing innovative solutions tailored to their needs.

Available Now

As of August 18, 2026, the Livi absorption device is accessible for purchase exclusively at MyLivi.com. This launch marks a pivotal moment in women’s intimate health, as it not only meets a practical need but also aims to destigmatize discussions around post-sex symptoms.

LiviWell is dedicated to advancing women’s intimate health and ensuring that they feel empowered in their choices. By introducing Livi, the company hopes to foster open conversations and normalize the importance of intimate health.

For more information, you can visit LiviWell's website or reach out to their media contact, Jess Woolridge at [email protected] .